How is lipid profile and morbidity risk in smokers and nonsmokers?

Caspian Journal of Internal Medicine

Volumn 1, Issue 4, 2010, Pages 128-133

  Mahjoub, Soleiman ^a   Ahmadi, Mahmoud Haji ^a   Faramarzi, Mahbobeh ^a   Jalali, Farzad ^a   Moazzezi, Zoleykha ^a   Sajjadi, Parvin ^a  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Babol; Cardiovascular diseases; Lipid profile; Risk factor; Smoking

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HUMAN; IRAN; LIPID ANALYSIS; MALE; MISCELLANEOUS NAMED GROUPS; MORBIDITY; NONSMOKER; SMOKING; SPECTROPHOTOMETRY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84861937936     PISSN: 20086164     EISSN: 20086172     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Chang JS. Parental smoking and childhood leukemia. Methods Mol Biol 2009; 472: 103-37.
2. Pryor WA. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect 1997; 105 Suppl 4: 875-82.
3. Nagler RM. Altered salivary profile in heavy smokers and its possible connection to oral cancer. Int J Biol Markers 2007; 22: 274-80.
4. Isik B, Ceylan A, Isik R. Oxidative stress m smokers and non-smokers. Inhal Toxicol 2007; 19: 767-9.
5. Lykkesfeldt J. malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta 2007; 380: 50-8. Epub 2007.
6. Brunner H, Cockcroft JR, Deanfield J, et al. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension J Hypertens 2005; 23: 233-46.
7. Deanfield JE, Selwyn AP. Character and causes of transient myocardial ischemia during daily life. Implications for treatment of patients with coronary disease. Am J Med 1986; 80: 18-24.
8. Rush JW, Denmss SG, Graham DA. Vascular nitric oxide and oxidative stress: determinants of endothelial adaptations to cardiovascular disease and to physical activity. Can J Appl Physiol 2005; 30: 442-74.
9. Zeiher AM, Schachinger V, Mmners J. Long-term cigarette smoking impairs endothehum-dependent coronary arterial vasodilator function. Circulation 1995; 92: 1094-100.
10. Woo KS, Robinson JT, Chook P, et al. Differences in the effect of cigarette smoking on endothelial function in chmese and White adults. Ann Intern Med 1997; 127: 372-5.
11. Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelmm-dependent dilation in healthy young adults. Circulation 1993; 88: 2149-55.
12. Mahjoub S, Maboudi A, Mazandram M. The relation between amilase activity and total protein with cigarette smoking. J Dent Sch 2007; 25: 73-7.
13. Mahjoub S, Taghikham M, Amir Rasouh H, Noohi F. Condition of Lipids and lipoproteins in normal subjects and in acute and stable phases of myocardial infarction. J Babol Umv Med Sci 2001; 3: 30-36.
14. Mahjoub S, Tammaddom A, Nikoo ML, Moghadamma AA. The effects of beta carotene and vitamin E on erythrocytes lipid peroxidation in beta-thalassemia. J Res Med Sci 2007; 12: 301-7.
15. Rosenson RS. Myocardial injury; the Acute Phase response and lipoprotein metabolism. J Am Coll cardiol 1993; 22: 933-40.
16. Ettinger WH, Varma VK, Sorci- Thomas M, et al. Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells. Artenoscler Thromb 1994; 14: 8-13.
17. Mclntyre TM, Hazen SL. Lipid oxidation and cardiovascular disease: introduction to a review series. Circ Res 2010; 107: 1167-9.
18. Stamler J, Daviglus ML, Garside DB, et al. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA 2000 284(3): 311-8.
19. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998; 98: 1487-94.
20. Sharrett AR, Ballantyne CM, Coady SA, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, hpoprotem(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001; 104: 1108-13.
21. Rosengren, A, Hagman M, Wedel H, Wilhelmsen L. Serum cholesterol and long term prognosis in middle-aged men with myocardial infarction and angina pectorahs. A 16-year follow-up of the primary prevention study in Goteborg, Sweden. Eur Health J 1997; 18: 754-61.
22. Craig SR, Amin RV, Russell DW, Paradise NF. Blood cholesterol screening influence of fasting state on cholesterol results and management decisions. J Gen Intern Med 2000; 15: 395-9.
23. Faas FH, Earleywme A, Smith G, Simmons DL. How should low - density lipoprotein Cholesterol concentration be determined? J Fam Pract 2002; 51: 972-5.
24. National Cholesterol Education Program: highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Us department of health and human services, public health service. National Institutes of Health, National Heart, Lung and Blood Institute. J Am Osteopath Assoc 1992; 92: 380-8.
25. Maclean DR, Petrasovits A, Connelly PW, et al. Plasma Lipids and Lipoprotein reference values, and the prevalence of dyslipoproteinemia m Canadian adults. Canadian Heart Health Surveys Research Group. Can J Cardiol 1999; 15: 434-44.
26. Azizi F, Rahmam M, Majid M, et al. Serum lipid levels in an Iranian population of children and adolescents: Tehran Lipid and Glucose study. Eur J Epidemiol 2001; 17: 281-8.
27. Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total cholesterol concentration and awareness, treatment, and control of hypercholesterolemia among U.S adult: finding from National Health and nutrition Examination Survey, 1999 to 2000. Circulation 2003; 107: 2185-9.
28. Maclean DR, Petrasovits A, Connelly PW, et al. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group. Can J cardiol 1996; 15: 434-44.
29. Singh RB, Rastogi V, Niaz MA, et al. Serum Cholesterol and coronary artery disease in populations with low cholesterol levels: The Indian Paradox. Int J Cardiol 1998; 65: 81-90.
30. Al-Nuaim AR, AL-Rubeaan K, Al-Mazrou Y, al-Attas o, al-Daghan N. Prevalence of hypercholesterolemia in Saudi Arabia, epidemiology Study. Int J Cardiol 1998; 54: 41-9.
31. Azizi F, Allahverdian S, Mirmiran P, Rahmam M, Mohammadi F, et al. Dietary factors and body mass index in a group of Iranian adolescents: Tehran Lipid and Glucose study-2. Int J Vitam Nutr Res 2001; 71: 123-7.
32. U.S Preventive Services Task Force Guide to clinical preventive service. Screening for Lipid Disorders in Adults. Office of Disease prevention and Health promotion, Washington, DC: 2010; 86-91. Avalible at www.ahty.gov/clinic/pocketgdlOl1/pocketgdlOll.pdf
33. Summary of the second Report of the National Cholesterol Education Program (NECP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult treatment panel II). JAMA 1993; 269: 3015-23.